Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	CNGB3 CNGB1 RYR1	1.68e-04	33	65	3	GO:0005217
GeneOntologyMolecularFunction	intracellularly cGMP-activated cation channel activity	CNGB3 CNGB1	2.17e-04	7	65	2	GO:0005223
GeneOntologyMolecularFunction	intracellularly cAMP-activated cation channel activity	CNGB3 CNGB1	4.62e-04	10	65	2	GO:0005222
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF13B KIF23 MYL6B MYO15A	5.94e-04	118	65	4	GO:0003774
GeneOntologyMolecularFunction	cytoskeletal protein binding	NEFM KIF13B BIN1 KIF23 MYLK MAP2 MAP4 KTN1 MYPN MYO15A MRTFA	7.73e-04	1099	65	11	GO:0008092
GeneOntologyMolecularFunction	intracellularly cyclic nucleotide-activated monoatomic cation channel activity	CNGB3 CNGB1	7.95e-04	13	65	2	GO:0005221
GeneOntologyMolecularFunction	cyclic nucleotide-activated monoatomic ion channel activity	CNGB3 CNGB1	7.95e-04	13	65	2	GO:0043855
GeneOntologyMolecularFunction	adenyl-nucleotide exchange factor activity	BAG3 HSPA4	1.07e-03	15	65	2	GO:0000774
GeneOntologyMolecularFunction	cGMP binding	CNGB3 CNGB1	1.22e-03	16	65	2	GO:0030553
GeneOntologyCellularComponent	supramolecular fiber	JPH1 EFHC2 NEFM KIF13B BIN1 KIF23 MAP2 MAP4 MYL6B MYPN BAG3 TPX2 RYR1	5.77e-05	1179	65	13	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	JPH1 EFHC2 NEFM KIF13B BIN1 KIF23 MAP2 MAP4 MYL6B MYPN BAG3 TPX2 RYR1	6.19e-05	1187	65	13	GO:0099081
GeneOntologyCellularComponent	Z disc	JPH1 BIN1 MYPN BAG3 RYR1	1.07e-04	151	65	5	GO:0030018
GeneOntologyCellularComponent	postsynaptic specialization	NEFM PRR12 GRID2IP MAP2 MAP4 PCLO DLGAP4 GABRA1	1.61e-04	503	65	8	GO:0099572
GeneOntologyCellularComponent	I band	JPH1 BIN1 MYPN BAG3 RYR1	1.67e-04	166	65	5	GO:0031674
GeneOntologyCellularComponent	intracellular cyclic nucleotide activated cation channel complex	CNGB3 CNGB1	1.98e-04	7	65	2	GO:0017071
GeneOntologyCellularComponent	contractile muscle fiber	JPH1 BIN1 MYL6B MYPN BAG3 RYR1	2.81e-04	290	65	6	GO:0043292
GeneOntologyCellularComponent	axon hillock	MAP2 TPX2	3.38e-04	9	65	2	GO:0043203
GeneOntologyCellularComponent	junctional membrane complex	JPH1 RYR1	3.38e-04	9	65	2	GO:0030314
GeneOntologyCellularComponent	junctional sarcoplasmic reticulum membrane	JPH1 RYR1	4.22e-04	10	65	2	GO:0014701
GeneOntologyCellularComponent	presynaptic cytoskeleton	NEFM PCLO	8.46e-04	14	65	2	GO:0099569
GeneOntologyCellularComponent	sarcomere	JPH1 BIN1 MYPN BAG3 RYR1	1.06e-03	249	65	5	GO:0030017
GeneOntologyCellularComponent	nuclear cyclin-dependent protein kinase holoenzyme complex	CCNK MED12	1.41e-03	18	65	2	GO:0019908
GeneOntologyCellularComponent	microtubule associated complex	KIF13B KIF23 MAP2 MAP4	1.59e-03	161	65	4	GO:0005875
GeneOntologyCellularComponent	myofibril	JPH1 BIN1 MYPN BAG3 RYR1	1.60e-03	273	65	5	GO:0030016
GeneOntologyCellularComponent	axon	NEFM KIF13B BIN1 MAP2 MAP4 PCLO MYPN TPX2 CNGB1	1.67e-03	891	65	9	GO:0030424
GeneOntologyCellularComponent	actin cytoskeleton	BIN1 MYLK MAP2 MYL6B BAG3 MYO15A FYB1	2.03e-03	576	65	7	GO:0015629
GeneOntologyCellularComponent	main axon	KIF13B BIN1 MAP2	2.69e-03	89	65	3	GO:0044304
GeneOntologyCellularComponent	postsynaptic density	NEFM PRR12 GRID2IP MAP2 MAP4 PCLO	2.75e-03	451	65	6	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	NEFM PRR12 GRID2IP MAP2 MAP4 PCLO	3.63e-03	477	65	6	GO:0032279
GeneOntologyCellularComponent	axon initial segment	BIN1 MAP2	3.66e-03	29	65	2	GO:0043194
HumanPheno	Hyperlordosis	BIN1 GLB1 SETD5 MYPN PRG4 MED12 RYR1 SON	9.08e-06	222	26	8	HP:0003307
HumanPheno	Lordosis	BIN1 GLB1 SETD5 MYPN PRG4 MED12 RYR1 SON	9.08e-06	222	26	8	HP:0002939
HumanPheno	Neonatal asphyxia	BIN1 MED12 RYR1	4.14e-05	14	26	3	HP:0012768
HumanPheno	Neonatal hypotonia	BIN1 SLF2 PCLO MED12 PDHX RYR1 SON	4.81e-05	202	26	7	HP:0001319
HumanPheno	Kyphosis	JPH1 BIN1 GLB1 SLF2 SETD5 MYPN BAG3 SPEN RYR1 SON	1.12e-04	510	26	10	HP:0002808
HumanPheno	Lumbar hyperlordosis	MYPN PRG4 MED12 RYR1 SON	1.19e-04	99	26	5	HP:0002938
MousePheno	abnormal Z line morphology	BIN1 MYPN BAG3 RYR1	1.64e-05	40	54	4	MP:0004091
MousePheno	abnormal I band morphology	BIN1 MYPN BAG3 RYR1	2.00e-05	42	54	4	MP:0030567
Domain	TAU_MAP_1	MAP2 MAP4	3.35e-05	3	63	2	PS00229
Domain	hSH3	PRAM1 FYB1	3.35e-05	3	63	2	IPR029294
Domain	hSH3	PRAM1 FYB1	3.35e-05	3	63	2	PF14603
Domain	TAU_MAP_2	MAP2 MAP4	3.35e-05	3	63	2	PS51491
Domain	Tubulin-binding	MAP2 MAP4	3.35e-05	3	63	2	PF00418
Domain	MAP_tubulin-bd_rpt	MAP2 MAP4	3.35e-05	3	63	2	IPR001084
Domain	MAP2/MAP4/Tau	MAP2 MAP4	3.35e-05	3	63	2	IPR027324
Domain	CRYSTALLIN_BETA_GAMMA	CRYBG2 CRYBG1	1.14e-03	15	63	2	PS50915
Domain	Crystall	CRYBG2 CRYBG1	1.14e-03	15	63	2	PF00030
Domain	Beta/gamma_crystallin	CRYBG2 CRYBG1	1.14e-03	15	63	2	IPR001064
Domain	XTALbg	CRYBG2 CRYBG1	1.14e-03	15	63	2	SM00247
Domain	MAM_1	ZAN PTPRM	1.30e-03	16	63	2	PS00740
Domain	cNMP-bd_CS	CNGB3 CNGB1	1.30e-03	16	63	2	IPR018488
Domain	MAM	ZAN PTPRM	1.47e-03	17	63	2	SM00137
Domain	MAM	ZAN PTPRM	1.65e-03	18	63	2	PF00629
Domain	G_crystallin-rel	CRYBG2 CRYBG1	1.65e-03	18	63	2	IPR011024
Domain	MAM_dom	ZAN PTPRM	1.65e-03	18	63	2	IPR000998
Domain	MAM_2	ZAN PTPRM	1.65e-03	18	63	2	PS50060
Domain	G_patch	RBM6 SON	2.71e-03	23	63	2	SM00443
Domain	G_patch_dom	RBM6 SON	2.71e-03	23	63	2	IPR000467
Domain	G_PATCH	RBM6 SON	2.71e-03	23	63	2	PS50174
Domain	G-patch	RBM6 SON	2.71e-03	23	63	2	PF01585
Domain	SH3_2	BIN1 MYO15A FYB1	3.07e-03	86	63	3	IPR011511
Domain	SH3_2	BIN1 MYO15A FYB1	3.07e-03	86	63	3	PF07653
Domain	Ricin_B_lectin	CRYBG2 CRYBG1	3.20e-03	25	63	2	PF00652
Domain	Galactose-bd-like	GLB1 CPXM2 PTPRM	3.94e-03	94	63	3	IPR008979
Domain	RICIN	CRYBG2 CRYBG1	4.00e-03	28	63	2	SM00458
Domain	RICIN_B_LECTIN	CRYBG2 CRYBG1	4.00e-03	28	63	2	PS50231
Domain	Ricin_B_lectin	CRYBG2 CRYBG1	4.58e-03	30	63	2	IPR000772
Domain	CNMP_BINDING_1	CNGB3 CNGB1	5.20e-03	32	63	2	PS00888
Domain	CNMP_BINDING_2	CNGB3 CNGB1	5.20e-03	32	63	2	PS00889
Domain	cNMP	CNGB3 CNGB1	5.86e-03	34	63	2	SM00100
Domain	cNMP_binding	CNGB3 CNGB1	5.86e-03	34	63	2	PF00027
Domain	SH3	PRAM1 BIN1 MYO15A FYB1	6.08e-03	216	63	4	SM00326
Domain	SH3	PRAM1 BIN1 MYO15A FYB1	6.08e-03	216	63	4	PS50002
Domain	cNMP-bd_dom	CNGB3 CNGB1	6.20e-03	35	63	2	IPR000595
Domain	CNMP_BINDING_3	CNGB3 CNGB1	6.20e-03	35	63	2	PS50042
Domain	ConA-like_dom	TRIM25 ZAN PTPRM RYR1	6.38e-03	219	63	4	IPR013320
Domain	SH3_domain	PRAM1 BIN1 MYO15A FYB1	6.49e-03	220	63	4	IPR001452
Domain	Ion_trans_dom	CNGB3 CNGB1 RYR1	6.74e-03	114	63	3	IPR005821
Domain	Ion_trans	CNGB3 CNGB1 RYR1	6.74e-03	114	63	3	PF00520
Domain	cNMP-bd-like	CNGB3 CNGB1	7.28e-03	38	63	2	IPR018490
Domain	Kinesin_motor_CS	KIF13B KIF23	8.44e-03	41	63	2	IPR019821
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PRR12 TRIM25 EP400 MAP4 SETD5 INTS13 KTN1 NACA TPX2 RBM6 CRYBG1 HELZ MRPL38 BRD3 EIF4G3 SPEN PRRC2A CCNK SPTY2D1 MED12 C6orf132 SON	1.56e-14	1497	65	22	31527615
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SRRM1 BIN1 KIF23 EP400 MAP4 BAG3 TPX2 RBM6 HELZ BRD3 SPEN PRG4 PRRC2A CCNK MRTFA SON	7.30e-13	774	65	16	15302935
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NEFM KIF23 EP400 MAP4 KTN1 BAG3 TPX2 CHORDC1 SPEN PRRC2A CCNK MED12 TAB3	2.55e-11	549	65	13	38280479
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SRRM1 KIF23 MAP4 MYPN BAG3 TPX2 RBM6 EIF4G3 SPEN PRRC2A MRTFA SON	1.48e-10	503	65	12	16964243
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	NEFM SRRM1 BIN1 MAP2 MAP4 PCLO DLGAP4 EIF4G3 PRRC2A GABRA1	9.45e-10	347	65	10	17114649
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	KIF23 TRIM25 EP400 MAP4 KTN1 NACA BAG3 TPX2 HELZ EIF4G3 PRRC2A CCNK HSPA4 SON	1.58e-09	934	65	14	33916271
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NEFM SRRM1 KIF23 MAP4 RBM6 HELZ EIF4G3 SPEN PRRC2A HSPA4 MED12 SON	2.82e-09	653	65	12	22586326
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	BIN1 MYLK MAP4 DLGAP4 TPX2 SPEN FYB1 PRG4 RYR1	1.09e-08	329	65	9	17474147
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	KIF23 MAP4 KTN1 NACA TPX2 RBM6 EIF4G3 PRRC2A SPTY2D1 MED12 PDHX SON	1.50e-08	759	65	12	35915203
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SRRM1 PRAM1 KIF23 EP400 MAP4 SLF2 KTN1 TPX2 RBM6 SPEN PRRC2A CCNK SON	2.02e-08	954	65	13	36373674
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ATF7 SRRM1 KIF23 TRIM25 EP400 MAP4 INTS13 TPX2 BRD3 MYO15A CCNK MED12 SON	4.11e-08	1014	65	13	32416067
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	NEFM ATF7 MAP2 SLF2 INTS13 BRD3 PRRC2A	7.18e-08	191	65	7	20195357
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PRR12 ATF7 SRRM1 KIF23 EP400 SLF2 INTS13 KTN1 TPX2 BRD3 SPEN TET3 SPTY2D1 SON	9.39e-08	1294	65	14	30804502
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	KIF23 TRIM25 MAP4 BAG3 HELZ CHORDC1 PRRC2A HSPA4	1.34e-07	315	65	8	26777405
Pubmed	Human transcription factor protein interaction networks.	PRR12 KIF23 ZFHX4 EP400 MYL6B NACA TPX2 RBM6 HELZ MRPL38 SPEN PRRC2A HSPA4 TAB3	3.14e-07	1429	65	14	35140242
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SRRM1 KIF23 ZFHX4 MAP4 BAG3 SPEN PRRC2A SON	3.76e-07	361	65	8	26167880
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B SRRM1 KIF23 MAP2 MAP4 SLF2 BAG3 HELZ EIF4G3 TAB3 C6orf132	5.32e-07	861	65	11	36931259
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PRR12 ATF7 PRAM1 TRIM25 EP400 MAP4 TPX2 SPEN PRRC2A CCNK HSPA4 MED12	8.34e-07	1103	65	12	34189442
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	NEFM KIF13B PTPRM PCLO FGF5 CNGB1	8.40e-07	171	65	6	20201926
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	BIN1 MAP2 MAP4 PCLO DLGAP4 KTN1 NACA HELZ EIF4G3 PDHX TAB3 GABRA1	1.17e-06	1139	65	12	36417873
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRIM25 EP400 TPX2 EIF4G3 SPEN MRTFA C6orf132 SON	1.39e-06	430	65	8	35044719
Pubmed	Proteomic analysis of in vivo phosphorylated synaptic proteins.	NEFM MAP2 MAP4 PCLO	3.04e-06	53	65	4	15572359
Pubmed	MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.	MAP2 MAP4 HSPA4	3.43e-06	16	65	3	14594945
Pubmed	KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells.	BAG3 HSPA4	3.44e-06	2	65	2	28859986
Pubmed	FOXR1 regulates stress response pathways and is necessary for proper brain development.	FOXR1 MAP2	3.44e-06	2	65	2	34723967
Pubmed	Interphase and monoastral-mitotic phenotypes of overexpressed MAP4 are modulated by free tubulin concentrations.	MAP2 MAP4	3.44e-06	2	65	2	12890753
Pubmed	Hsp70 in cancer: back to the future.	BAG3 HSPA4	3.44e-06	2	65	2	25347739
Pubmed	Lipid-binding hSH3 domains in immune cell adapter proteins.	PRAM1 FYB1	3.44e-06	2	65	2	16831444
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	KIF23 EP400 SLF2 TPX2 RBM6 SPTY2D1	3.81e-06	222	65	6	37071664
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	MAP4 NACA HELZ EIF4G3 PRRC2A HSPA4	3.91e-06	223	65	6	20020773
Pubmed	Identification of VCP/p97, carboxyl terminus of Hsp70-interacting protein (CHIP), and amphiphysin II interaction partners using membrane-based human proteome arrays.	BIN1 DLGAP4 HSPA4	4.16e-06	17	65	3	16275660
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	JPH1 NEFM MAP2 PCLO DLGAP4 PRRC2A	4.79e-06	231	65	6	16452087
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	JPH1 SRRM1 BIN1 KIF23 MYL6B NACA BAG3 TPX2 RBM6 PRRC2A	7.38e-06	916	65	10	32203420
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SRRM1 TRIM25 EP400 MAP4 MYL6B KTN1 NACA TPX2 PRRC2A CCNK SPTY2D1 SON	7.81e-06	1371	65	12	36244648
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	JPH1 BIN1 KIF23 GLB1 EP400 KTN1 NACA TPX2 HELZ	8.71e-06	733	65	9	34672954
Pubmed	Target deletion of the cytoskeleton-associated protein palladin does not impair neurite outgrowth in mice.	NEFM MAP2	1.03e-05	3	65	2	19730728
Pubmed	Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization.	NEFM MAP2	1.03e-05	3	65	2	11581286
Pubmed	Correlation of BAG-3 and heat shock protein 70 with CD30 expression in T-cell lymphomas.	BAG3 HSPA4	1.03e-05	3	65	2	24492285
Pubmed	CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins.	BAG3 HSPA4	1.03e-05	3	65	2	12750378
Pubmed	Cloning and tissue expression of the mouse ortholog of AIM1, a betagamma-crystallin superfamily member.	CRYBG2 CRYBG1	1.03e-05	3	65	2	9716656
Pubmed	Segregation of a mutation in CNGB1 encoding the beta-subunit of the rod cGMP-gated channel in a family with autosomal recessive retinitis pigmentosa.	CNGB3 CNGB1	1.03e-05	3	65	2	11379879
Pubmed	Effects of three microtubule-associated proteins (MAP2, MAP4, and Tau) on microtubules' physical properties and neurite morphology.	MAP2 MAP4	1.03e-05	3	65	2	37258650
Pubmed	Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy.	BAG3 HSPA4	1.03e-05	3	65	2	29986884
Pubmed	Noncentrosomal microtubules and type II myosins potentiate epidermal cell adhesion and barrier formation.	MAP2 MAP4	1.03e-05	3	65	2	23091070
Pubmed	The B3 Subunit of the Cone Cyclic Nucleotide-gated Channel Regulates the Light Responses of Cones and Contributes to the Channel Structural Flexibility.	CNGB3 CNGB1	1.03e-05	3	65	2	26893377
Pubmed	Vinculin knockout results in heart and brain defects during embryonic development.	NEFM MAP2	1.03e-05	3	65	2	9486805
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	PRR12 EP400 INTS13 TPX2 CCNK MED12	1.12e-05	268	65	6	33640491
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NEFM BIN1 TRIM25 MAP2 MAP4 PCLO DLGAP4 KTN1 EIF4G3 PRRC2A HSPA4 PDHX	1.20e-05	1431	65	12	37142655
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	NEFM TRIM25 MAP4 RBM6 PRRC2A HSPA4	1.27e-05	274	65	6	34244482
Pubmed	A hybrid photoreceptor expressing both rod and cone genes in a mouse model of enhanced S-cone syndrome.	MYLK CNGB3 HELZ CNGB1	1.66e-05	81	65	4	16110338
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	JPH1 SRRM1 TRIM25 GLB1 MAP2 KTN1 BAG3 MRPL38 CHORDC1 EIF4G3 HSPA4 PDHX	1.76e-05	1487	65	12	33957083
Pubmed	Cyclic nucleotide-gated channel subunit glycosylation regulates matrix metalloproteinase-dependent changes in channel gating.	CNGB3 CNGB1	2.06e-05	4	65	2	24164424
Pubmed	Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells.	MAP2 MAP4	2.06e-05	4	65	2	10542369
Pubmed	Expression of MUK/DLK/ZPK, an activator of the JNK pathway, in the nervous systems of the developing mouse embryo.	NEFM MAP2	2.06e-05	4	65	2	15749080
Pubmed	BAG3 expression in glioblastoma cells promotes accumulation of ubiquitinated clients in an Hsp70-dependent manner.	BAG3 HSPA4	2.06e-05	4	65	2	21233200
Pubmed	High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.	TPX2 CRYBG1	2.06e-05	4	65	2	22761906
Pubmed	Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics.	MAP2 MAP4	2.06e-05	4	65	2	8631898
Pubmed	Impaired channel targeting and retinal degeneration in mice lacking the cyclic nucleotide-gated channel subunit CNGB1.	CNGB3 CNGB1	2.06e-05	4	65	2	15634774
Pubmed	BAG3 and BAG6 differentially affect the dynamics of stress granules by targeting distinct subsets of defective polypeptides released from ribosomes.	BAG3 HSPA4	2.06e-05	4	65	2	32696179
Pubmed	Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3.	BAG3 HSPA4	2.06e-05	4	65	2	19229298
Pubmed	Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort.	BIN1 RYR1	2.06e-05	4	65	2	25957634
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	PRR12 KIF23 EP400 SLF2 INTS13 TPX2 MED12	2.20e-05	453	65	7	29656893
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	TRIM25 PCLO HELZ EIF4G3 PRRC2A MED12 GABRA1	2.50e-05	462	65	7	31138677
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	SRRM1 KIF23 TRIM25 EP400 TPX2 BRD3 SPEN MED12	2.67e-05	645	65	8	25281560
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	PRR12 SRRM1 KIF23 KTN1 TPX2 BRD3 PRRC2A CCNK SON	2.73e-05	847	65	9	35850772
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CRYBG2 EP400 TPX2 CRYBG1 BRD3 SPEN CCNK	2.75e-05	469	65	7	27634302
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NEFM ATF7 FOXR1 ZFHX4 EP400 KTN1 TPX2 MRPL38 SPEN	2.99e-05	857	65	9	25609649
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	ATF7 ZFHX4 MYL6B KTN1 MYPN PRRC2A	3.08e-05	321	65	6	32098917
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NEFM SRRM1 EP400 MAP2 RBM6 BRD3 SPEN CCNK MED12 SON	3.09e-05	1082	65	10	38697112
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	EFHC2 NEFM KIF13B GLB1 SETD5 MYL6B KTN1 BAG3 HELZ MRPL38 CHORDC1	3.10e-05	1321	65	11	27173435
Pubmed	Liprin-α-1 is a novel component of the murine neuromuscular junction and is involved in the organization of the postsynaptic machinery.	NEFM RYR1	3.43e-05	5	65	2	28831123
Pubmed	Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain.	NEFM MAP2	3.43e-05	5	65	2	19830834
Pubmed	The heteromeric cyclic nucleotide-gated channel adopts a 3A:1B stoichiometry.	CNGB3 CNGB1	3.43e-05	5	65	2	12432397
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	SRRM1 NACA BAG3 HELZ PRRC2A HSPA4 SPTY2D1 SON	3.80e-05	678	65	8	30209976
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	KIF23 TRIM25 MAP4 NACA TPX2 RBM6 HSPA4	3.82e-05	494	65	7	26831064
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	JPH1 BIN1 KTN1 MYPN CHORDC1 RYR1 SON	3.97e-05	497	65	7	23414517
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	JPH1 SRRM1 ZFHX4 EP400 SETD5 INTS13 HELZ BRD3 PDHX SON	4.01e-05	1116	65	10	31753913
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	NEFM BIN1 MAP2 MAP4 PCLO KTN1 EIF4G3	4.02e-05	498	65	7	36634849
Pubmed	An unappreciated role for RNA surveillance.	ZAN MAP2 MAP4 SON	4.11e-05	102	65	4	14759258
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	SRRM1 ZFHX4 BRD3 SPEN	4.27e-05	103	65	4	32744500
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	SRRM1 MAP4 NACA SPEN RYR1	4.50e-05	208	65	5	33230847
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	SRRM1 TRIM25 GLB1 RBM6 HELZ	4.93e-05	212	65	5	33853758
Pubmed	cGMP and cyclic nucleotide-gated channels participate in mouse sperm capacitation.	CNGB3 CNGB1	5.13e-05	6	65	2	22192355
Pubmed	Postsynaptic CaV1.1-driven calcium signaling coordinates presynaptic differentiation at the developing neuromuscular junction.	PCLO RYR1	5.13e-05	6	65	2	31804576
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	SRRM1 KIF23 MAP4 PRRC2A	5.15e-05	108	65	4	19531213
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	JPH1 MAP4 KTN1 EIF4G3 PRRC2A CCNK HSPA4 MED12	5.15e-05	708	65	8	39231216
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	TRIM25 MAP4 KTN1 HELZ EIF4G3 SPEN PRRC2A SON	6.02e-05	724	65	8	36232890
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	SRRM1 MAP4 HELZ EIF4G3 FYB1 PRRC2A	6.78e-05	370	65	6	22922362
Pubmed	Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation.	BIN1 RYR1	7.18e-05	7	65	2	29130937
Pubmed	p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation.	NEFM MAP2	7.18e-05	7	65	2	11283609
Pubmed	The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development.	NEFM MAP2	7.18e-05	7	65	2	7956838
Pubmed	Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1.	TRIM25 EIF4G3	7.18e-05	7	65	2	35780119
Pubmed	The cytoskeleton of the myenteric neurons during murine embryonic life.	NEFM MAP2	7.18e-05	7	65	2	10221457
Pubmed	Mitophagy mediated by BNIP3 and BNIP3L/NIX in urothelial cells of the urinary bladder of cattle harbouring bovine papillomavirus infection.	BAG3 HSPA4	7.18e-05	7	65	2	31500722
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	NACA BAG3 HELZ PRRC2A SON	7.54e-05	232	65	5	25515538
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	NEFM MAP4 NACA PRRC2A HSPA4 PDHX TAB3	7.59e-05	551	65	7	34728620
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	NEFM EP400 MAP2 MAP4 NACA MYO15A HSPA4	8.77e-05	564	65	7	21565611
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	JPH1 TRIM25 MAP4 KTN1 BAG3 CHORDC1 HSPA4	9.17e-05	568	65	7	37774976
Pubmed	Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain.	NEFM MAP2	9.56e-05	8	65	2	10712642
Pubmed	The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells.	NEFM MAP2	9.56e-05	8	65	2	10627606
Interaction	HECTD1 interactions	KIF23 TRIM25 MAP4 KTN1 NACA TPX2 RBM6 EIF4G3 PRRC2A CCNK HSPA4 SPTY2D1 MED12 PDHX SON	4.02e-07	984	65	15	int:HECTD1
Interaction	SIRT7 interactions	NEFM SRRM1 KIF23 TRIM25 MAP4 RBM6 HELZ EIF4G3 SPEN PRRC2A HSPA4 MED12 SON	5.94e-07	744	65	13	int:SIRT7
Interaction	PPP1CA interactions	KIF13B ATF7 SRRM1 KIF23 TRIM25 MAP4 MYPN NACA BRD3 HSPA4 PDHX SON	1.97e-06	696	65	12	int:PPP1CA
Interaction	NAA40 interactions	KIF23 TRIM25 EP400 MAP4 KTN1 NACA BAG3 TPX2 HELZ EIF4G3 PRRC2A CCNK HSPA4 SON	2.20e-06	978	65	14	int:NAA40
Interaction	MEN1 interactions	PRR12 KIF13B ATF7 SRRM1 KIF23 EP400 KTN1 TPX2 SPEN PRRC2A CCNK HSPA4 MED12 SON	3.98e-06	1029	65	14	int:MEN1
Interaction	GUSBP5 interactions	KIF23 ZFHX4 HELZ EIF4G3 SPEN	4.33e-06	75	65	5	int:GUSBP5
Interaction	DHX8 interactions	SRRM1 TRIM25 MYPN BAG3 RBM6 SPEN CCNK SON	4.35e-06	292	65	8	int:DHX8
Interaction	BAG2 interactions	KIF13B KIF23 TRIM25 BAG3 TPX2 BRD3 EIF4G3 SPEN HSPA4 MED12 MRTFA	4.37e-06	622	65	11	int:BAG2
Interaction	WWTR1 interactions	NEFM KIF23 TRIM25 EP400 KTN1 BAG3 CHORDC1 PRRC2A TAB3	8.05e-06	422	65	9	int:WWTR1
Interaction	HSP90AB1 interactions	EFHC2 KIF23 TRIM25 KTN1 BAG3 CHORDC1 MYO15A SPEN TET3 PRRC2A HSPA4 C6orf132 GABRA1	9.82e-06	960	65	13	int:HSP90AB1
Interaction	SMC5 interactions	SRRM1 PRAM1 KIF23 EP400 MAP4 SLF2 KTN1 TPX2 RBM6 SPEN PRRC2A CCNK SON	1.52e-05	1000	65	13	int:SMC5
Interaction	KCNA3 interactions	JPH1 SRRM1 MAP4 KTN1 NACA EIF4G3 SPEN PRRC2A CCNK HSPA4 MED12 RYR1	1.92e-05	871	65	12	int:KCNA3
Interaction	MYCN interactions	NEFM SRRM1 FOXR1 EP400 MAP2 MYL6B KTN1 NACA RBM6 MRPL38 EIF4G3 PRRC2A HSPA4 SPTY2D1 SON	2.38e-05	1373	65	15	int:MYCN
Interaction	KIF20A interactions	NEFM SRRM1 KIF23 GLB1 MYL6B PCLO KTN1 BAG3 TPX2 HELZ TET3 PRRC2A SON	2.59e-05	1052	65	13	int:KIF20A
Interaction	SHANK3 interactions	NEFM ZAN MAP2 MAP4 DLGAP4 KTN1 NACA MYO15A EIF4G3	2.90e-05	496	65	9	int:SHANK3
Interaction	PPP1R9B interactions	NEFM BIN1 KIF23 TRIM25 MAP2 PCLO DLGAP4 NACA HSPA4 GABRA1	2.99e-05	626	65	10	int:PPP1R9B
Interaction	MYO9B interactions	NEFM KIF23 TRIM25 MYL6B BRD3	3.20e-05	113	65	5	int:MYO9B
Interaction	YAP1 interactions	NEFM GLB1 MAP2 MAP4 MYL6B BAG3 TPX2 SPEN PRRC2A CCNK HSPA4 MED12 TAB3	3.93e-05	1095	65	13	int:YAP1
Interaction	BMI1 interactions	SRRM1 TRIM25 KTN1 RBM6 HELZ EIF4G3 SPEN PRRC2A MED12 SON	4.61e-05	659	65	10	int:BMI1
Interaction	PDLIM3 interactions	MYPN BAG3 RYR1	6.18e-05	24	65	3	int:PDLIM3
Interaction	FOS interactions	NEFM ATF7 GLB1 EP400 MYL6B NACA CRYBG1	6.43e-05	312	65	7	int:FOS
Interaction	MYL12B interactions	KIF23 TRIM25 MYLK MYL6B GABRA1	8.31e-05	138	65	5	int:MYL12B
Interaction	DPPA4 interactions	FOXR1 PRAM1 PCLO NACA SPEN	8.90e-05	140	65	5	int:DPPA4
Interaction	PRPF40A interactions	SRRM1 KIF23 MRPL38 BRD3 SPEN PRG4 GABRA1 SON	9.04e-05	446	65	8	int:PRPF40A
Interaction	CRYBG2 interactions	CRYBG2 HELZ EIF4G3	1.10e-04	29	65	3	int:CRYBG2
Interaction	NUP50 interactions	GLB1 NACA RBM6 HELZ SPEN CCNK SON	1.12e-04	341	65	7	int:NUP50
Interaction	EYA4 interactions	PRR12 BAG3 HELZ CCNK SPTY2D1 TAB3	1.32e-04	243	65	6	int:EYA4
Interaction	CEBPA interactions	PRR12 ATF7 PRAM1 TRIM25 EP400 MAP4 INTS13 TPX2 SPEN PRRC2A CCNK HSPA4 MED12	1.45e-04	1245	65	13	int:CEBPA
Interaction	MARK4 interactions	TRIM25 MAP2 MAP4 HSPA4	1.50e-04	83	65	4	int:MARK4
Interaction	PNPLA5 interactions	KIF23 BAG3 HSPA4	1.63e-04	33	65	3	int:PNPLA5
Interaction	XRCC6 interactions	BIN1 KIF23 TRIM25 EP400 MAP4 INTS13 TPX2 CHORDC1 SPEN CCNK PDHX	1.70e-04	928	65	11	int:XRCC6
Interaction	ZBTB7B interactions	ATF7 TRIM25 ZFHX4 MYL6B KTN1 MYPN PRRC2A	1.73e-04	366	65	7	int:ZBTB7B
Interaction	CIT interactions	NEFM SRRM1 KIF23 EP400 SETD5 MYL6B PCLO KTN1 NACA TPX2 BRD3 PRRC2A C6orf132 SON	1.76e-04	1450	65	14	int:CIT
Interaction	PRPF8 interactions	SRRM1 KIF23 TRIM25 MAP4 NACA BAG3 RBM6 SPEN HSPA4 MED12	1.78e-04	776	65	10	int:PRPF8
Interaction	BRD3 interactions	JPH1 SRRM1 TRIM25 SETD5 MYL6B TPX2 BRD3 SON	1.82e-04	494	65	8	int:BRD3
Interaction	RCOR1 interactions	NEFM TRIM25 ZFHX4 BAG3 SPEN HSPA4 MED12 MRTFA	1.82e-04	494	65	8	int:RCOR1
Interaction	HNRNPAB interactions	KIF23 TRIM25 MYLK MAP4 PCLO DLGAP4 HSPA4	1.88e-04	371	65	7	int:HNRNPAB
Interaction	DENND2D interactions	MYPN BAG3 HSPA4	2.12e-04	36	65	3	int:DENND2D
Interaction	CNGB1 interactions	SRRM1 CNGB1	2.13e-04	7	65	2	int:CNGB1
Interaction	MED23 interactions	SRRM1 EP400 BRD3 SPEN CCNK MED12	2.15e-04	266	65	6	int:MED23
Interaction	EIF4A2 interactions	KIF23 TRIM25 BAG3 EIF4G3 PRRC2A	2.27e-04	171	65	5	int:EIF4A2
Interaction	TARDBP interactions	KIF23 TRIM25 MAP4 NACA HELZ EIF4G3 PRRC2A HSPA4	2.58e-04	520	65	8	int:TARDBP
Interaction	SOX9 interactions	PRR12 EP400 SPEN MED12	2.73e-04	97	65	4	int:SOX9
Interaction	SNN interactions	TRIM25 BAG3	2.83e-04	8	65	2	int:SNN
Interaction	MYPN interactions	TRIM25 MYPN RYR1	2.91e-04	40	65	3	int:MYPN
Interaction	ALG13 interactions	PRR12 RBM6 HELZ PRRC2A CCNK	3.11e-04	183	65	5	int:ALG13
Interaction	G3BP1 interactions	KIF23 TRIM25 MAP4 BAG3 TPX2 CRYBG1 HELZ CHORDC1 PRRC2A HSPA4	3.20e-04	835	65	10	int:G3BP1
Interaction	CTBP1 interactions	PRR12 TRIM25 EP400 PCLO BAG3 HELZ SPEN	3.26e-04	406	65	7	int:CTBP1
Interaction	SKAP1 interactions	JPH1 PRAM1 SETD5 FYB1	3.30e-04	102	65	4	int:SKAP1
Interaction	SSRP1 interactions	SRRM1 KIF23 SETD5 INTS13 BRD3 PRRC2A SPTY2D1 MRTFA SON	3.35e-04	685	65	9	int:SSRP1
Interaction	MYO5B interactions	EFHC2 KIF23 TRIM25 GABRA1	3.43e-04	103	65	4	int:MYO5B
Interaction	YWHAB interactions	KIF13B BIN1 KIF23 TRIM25 GRID2IP MAP2 BAG3 CHORDC1 HSPA4 C6orf132 SON	3.65e-04	1014	65	11	int:YWHAB
Interaction	VASP interactions	TRIM25 DLGAP4 BAG3 FYB1 MRTFA C6orf132	3.67e-04	294	65	6	int:VASP
Interaction	H2BC21 interactions	PRR12 KIF23 EP400 PTPRM PCLO TPX2 CRYBG1 FYB1 PRRC2A	3.76e-04	696	65	9	int:H2BC21
Interaction	TTN interactions	JPH1 NEFM KTN1 MYPN SPEN RYR1	4.02e-04	299	65	6	int:TTN
Interaction	KLF5 interactions	PRR12 TRIM25 EP400 RBM6 PRRC2A	4.16e-04	195	65	5	int:KLF5
Interaction	MRGBP interactions	FOXR1 EP400 BRD3 HSPA4	4.25e-04	109	65	4	int:MRGBP
Interaction	SPAG16 interactions	SETD5 BAG3	4.53e-04	10	65	2	int:SPAG16
Interaction	SRPK2 interactions	SRRM1 TRIM25 ZFHX4 MAP4 BAG3 BRD3 SPEN PRRC2A SON	4.67e-04	717	65	9	int:SRPK2
Interaction	FOXP3 interactions	SRRM1 FOXR1 MAP4 HELZ EIF4G3 FYB1 PRRC2A	4.72e-04	432	65	7	int:FOXP3
Interaction	FUBP1 interactions	SRRM1 TRIM25 MRPL38 CHORDC1 SPEN SON	4.78e-04	309	65	6	int:FUBP1
Interaction	SLX4 interactions	KIF23 TRIM25 EP400 SLF2 NACA TPX2 RBM6 SPTY2D1	4.88e-04	572	65	8	int:SLX4
Interaction	NR1I3 interactions	MAP4 HSPA4 MED12	4.99e-04	48	65	3	int:NR1I3
GeneFamily	Beta-gamma crystallin domain containing	CRYBG2 CRYBG1	1.43e-05	3	40	2	1360
GeneFamily	Cyclic nucleotide gated channels	CNGB3 CNGB1	2.12e-04	10	40	2	250
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	RBM6 SON	1.07e-03	22	40	2	579
GeneFamily	Ataxins\|Trinucleotide repeat containing	EP400 MED12	1.39e-03	25	40	2	775
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF13B KIF23	4.64e-03	46	40	2	622
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYLK PTPRM MYPN	5.38e-03	161	40	3	593
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	ST6GALNAC1 EFHC2 PTPRM BAG3 CRYBG1 HELZ FYB1 SPTY2D1	2.85e-08	195	65	8	M4195
Coexpression	GSE17721_LPS_VS_CPG_8H_BMDC_UP	NEFM EP400 MAP4 TPX2 IFI35 TAB3	1.04e-05	200	65	6	M4003
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	SRRM1 MAP4 RBM6 BRD3 RYR1 MRTFA C6orf132 SON PCOLCE	1.89e-05	610	65	9	M3854
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	SRRM1 MAP4 RBM6 BRD3 RYR1 MRTFA C6orf132 SON PCOLCE	3.11e-05	650	65	9	MM1042
Coexpression	MARSON_BOUND_BY_FOXP3_UNSTIMULATED	ST6GALNAC1 KIF23 GLB1 SETD5 INTS13 MYL6B RBM6 HELZ CHORDC1 FYB1 HSPA4 SPTY2D1	4.65e-05	1239	65	12	M1743
Coexpression	ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN	SRRM1 ZAN SPEN SON	6.00e-05	85	65	4	M41085
Coexpression	MARSON_BOUND_BY_FOXP3_UNSTIMULATED	ST6GALNAC1 KIF23 GLB1 SETD5 INTS13 MYL6B RBM6 HELZ CHORDC1 FYB1 HSPA4 SPTY2D1	6.23e-05	1277	65	12	MM1032
Coexpression	IBRAHIM_NRF1_UP	MAP4 INTS13 KTN1 NACA BAG3 RBM6 HSPA4	8.07e-05	420	65	7	M42509
Coexpression	CYCLIN_D1_UP.V1_UP	BIN1 TRIM25 GLB1 PRRC2A MED12	1.02e-04	187	65	5	M2654
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP	EFHC2 PTPRM BAG3 CRYBG1 SPTY2D1	1.08e-04	189	65	5	M4199
Coexpression	DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS	JPH1 BIN1 MYL6B MYPN RYR1	1.22e-04	194	65	5	M40093
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP	PRR12 BIN1 MYL6B KTN1 FGF5	1.22e-04	194	65	5	M4181
Coexpression	GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP	JPH1 BIN1 ZFHX4 DLGAP4 PCOLCE	1.25e-04	195	65	5	M3098
Coexpression	MARTINEZ_TP53_TARGETS_DN	SRRM1 MAP4 BRD3 RYR1 MRTFA C6orf132 SON PCOLCE	1.37e-04	615	65	8	M8673
Coexpression	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	CPXM2 EIF4G3 SPEN IFI35 SON	1.37e-04	199	65	5	M7451
Coexpression	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	RBM6 HELZ SPEN FYB1 TET3	1.37e-04	199	65	5	M4460
Coexpression	GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP	MAP4 DLGAP4 RBM6 CRYBG1 FGF5	1.40e-04	200	65	5	M9605
Coexpression	TSUTSUMI_FBXW8_TARGETS	MYPN RYR1	2.16e-04	9	65	2	MM888
Coexpression	TSUTSUMI_FBXW8_TARGETS	MYPN RYR1	2.16e-04	9	65	2	M2187
Coexpression	MARTINEZ_TP53_TARGETS_DN	SRRM1 MAP4 BRD3 RYR1 MRTFA C6orf132 SON PCOLCE	2.19e-04	659	65	8	MM1040
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JPH1 MYLK ZFHX4 MYPN TAB3	6.37e-06	176	66	5	4ed73c73972334f6dc4229920205547823252fa0
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B ZFHX4 CPXM2 PRG4 PCOLCE	9.72e-06	192	66	5	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ZFHX4 CPXM2 PRG4 PCOLCE	1.10e-05	197	66	5	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FOXR1 FGF5 MYO15A FYB1	6.22e-05	144	66	4	8bd042f12186f36bc5aabf6a0232270a448f4b58
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	JPH1 BIN1 MYPN RYR1	6.22e-05	144	66	4	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 ZFHX4 MAP2 FYB1	1.15e-04	169	66	4	15a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBG2 KIF23 TPX2 PRG4	1.15e-04	169	66	4	dbf9b1d52b29bf4b60bd23012cc1ea82d344747f
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 MYLK CPXM2 MAP2	1.32e-04	175	66	4	d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 MYLK CPXM2 MAP2	1.32e-04	175	66	4	cf15465855602ba135752c18755e3e058dbd42ec
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRR12 CRYBG2 KIF23 TAB3	1.35e-04	176	66	4	91ad2c34144f72283ca112fd3b3784f2f6259f65
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JPH1 MYLK CPXM2 MYPN	1.38e-04	177	66	4	c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	ST6GALNAC1 BAG3 CHORDC1 IFI35	1.41e-04	178	66	4	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	FF-Differ-KC\|World / shred by cell class for mouse tongue	ZFHX4 MAP2 PCLO RYR1	1.44e-04	179	66	4	1526a130565a97c291a25a7a988089bffc1515c1
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEFM BAG3 CHORDC1 FYB1	1.44e-04	179	66	4	02218c048e4dec0c0a3d63d2abb4feb4c3e82697
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	MYLK CPXM2 PRG4 PCOLCE	1.50e-04	181	66	4	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MYL6B MYPN EIF4G3 GABRA1	1.54e-04	182	66	4	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN ZFHX4 PCLO MYO15A	1.60e-04	184	66	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN ZFHX4 PCLO MYO15A	1.60e-04	184	66	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN ZFHX4 PCLO MYO15A	1.60e-04	184	66	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRAM1 BIN1 BAG3 SON	1.70e-04	187	66	4	ba822dbceb47257129d6a8c9639c08d76de6d6a3
ToppCell	droplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK CPXM2 PRG4 PCOLCE	1.77e-04	189	66	4	1821ae4a6e37ee4c6308071883f3f447a7c53c53
ToppCell	droplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK CPXM2 PRG4 PCOLCE	1.77e-04	189	66	4	1e4d7e8dc98b3d70351e6a6c2aaf9ca01f141b8f
ToppCell	droplet-Pancreas-PANCREAS-30m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK CPXM2 PRG4 PCOLCE	1.77e-04	189	66	4	1dc415ed41815f4296dafd8cf7f3e014c44db1db
ToppCell	facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 CPXM2 BAG3 PCOLCE	1.81e-04	190	66	4	dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd
ToppCell	facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 CPXM2 BAG3 PCOLCE	1.81e-04	190	66	4	0bb06df3d5a50416854370f234718c6cec3d773b
ToppCell	facs-SCAT-Fat-24m-Mesenchymal\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 CPXM2 BAG3 PCOLCE	1.81e-04	190	66	4	008290bb5c79446681dd6bf354336c57ad0d6f13
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRAM1 CRYBG1 FYB1 RYR1	1.81e-04	190	66	4	773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYLK ZFHX4 PRG4 PCOLCE	1.85e-04	191	66	4	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 PCOLCE	1.85e-04	191	66	4	96ff4cfbdcaec4b8568f9482d732dddd399121d3
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYLK ZFHX4 PRG4 PCOLCE	1.85e-04	191	66	4	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 PCLO C6orf132 PCOLCE	1.88e-04	192	66	4	e19e3e8edcc08e4a67873bfb6e46489ca6c8756a
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 PCLO C6orf132 PCOLCE	1.88e-04	192	66	4	61c2caf6c838132ed5faa8791c288f2149eba2c8
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BAG3 CHORDC1 HSPA4 MRTFA	1.88e-04	192	66	4	3f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 MAP2	1.92e-04	193	66	4	1043b28503bfaa0d5a82ec358bc86cbde73ea8f2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 PCOLCE	1.92e-04	193	66	4	18e11d515147accef9aee26e934b358b445e18e2
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BAG3 CHORDC1 HSPA4 MRTFA	1.92e-04	193	66	4	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRYBG2 PTPRM CRYBG1 C6orf132	1.92e-04	193	66	4	a5695ce2e24a62026ae28f3dea07ca4a435206b8
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 MAP2	1.92e-04	193	66	4	0266a4fdf436d83ec1d9392abba8c6ec5166970a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 PCOLCE	1.92e-04	193	66	4	7766f495f2f945802ef9a5b994cd00bb64d0dfe3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRAM1 BIN1 FYB1 SON	1.92e-04	193	66	4	b52d5661edff83ac4c5fe2bf89d6672016bb827b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 PCOLCE	1.92e-04	193	66	4	ce3e8cf30b7b4d5c7a8f3d64c21d81d2c3cab5c1
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KIF23 MAP2 TPX2 SON	1.96e-04	194	66	4	7a66bd7d4fc9c6db861cedd2487f241e406869d1
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 PCOLCE	1.96e-04	194	66	4	3bff2e4eb16719ab7419b2f94c9c6e7302aa6629
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	VSTM4 MYLK PRG4 PCOLCE	1.96e-04	194	66	4	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VSTM4 KIF23 TPX2 PCOLCE	1.96e-04	194	66	4	d840c1949c328779426c9172e02da09e968f0567
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK CPXM2 PCOLCE	1.96e-04	194	66	4	fdaf61cbe7f77ff5358d150b38adb1fe3778e961
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 CPXM2 PRG4 PCOLCE	2.00e-04	195	66	4	d2c9c58b46bf96f9a536e177b995e340b55c6750
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JPH1 KIF13B ZFHX4 PCOLCE	2.00e-04	195	66	4	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK ZFHX4 PCOLCE	2.04e-04	196	66	4	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MYLK ZFHX4 PCOLCE	2.04e-04	196	66	4	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	droplet-Tongue-TONGUE\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRID2IP CPXM2 KTN1 TET3	2.04e-04	196	66	4	44a30b1a5f3d8c845e5f3bd17d8102a7449f555b
ToppCell	droplet-Tongue-TONGUE-1m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRID2IP CPXM2 KTN1 TET3	2.04e-04	196	66	4	9935bdb10789e8cfc922dca526ca3bf8317fe270
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 CPXM2 PRG4 PCOLCE	2.04e-04	196	66	4	61bee32ca299219f31a30b57124e44e85b798e9f
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRID2IP CPXM2 KTN1 TET3	2.04e-04	196	66	4	a85f5f1e6acc798e9e02b1a21e0ffe87a323c333
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP2 MAP4 MYL6B GABRA1	2.04e-04	196	66	4	379132e944be2b9dcdf1a787293a48313956902c
ToppCell	facs-Trachea\|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPXM2 BAG3 PRG4 PCOLCE	2.04e-04	196	66	4	8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEFM KIF13B MAP2 CNGB1	2.04e-04	196	66	4	e874aa82a20bb59582c8cd7f8d30b2ed02903a85
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BAG3 CHORDC1 FYB1 HSPA4	2.04e-04	196	66	4	349502ed53fbf365f8f6f9e27af7f421139ae169
ToppCell	facs-Trachea\|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPXM2 BAG3 PRG4 PCOLCE	2.04e-04	196	66	4	34020d6553309daa269dff05de0a8567211ea4d2
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP2 BAG3 CHORDC1 HSPA4	2.08e-04	197	66	4	d9a5b6171867de21d4ef12aa5a802fb4de9e0c00
ToppCell	ILEUM-non-inflamed-(5)_Plasma-(5)_Plasmablasts\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SRRM1 KIF23 TPX2 FYB1	2.08e-04	197	66	4	ffc55028052311ed8d173a2db1a9f664391fe8d8
ToppCell	5'-GW_trimst-1.5-LargeIntestine\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK ZFHX4 BAG3 CHORDC1	2.08e-04	197	66	4	0b2ad6a933ff1a325649cc8f139380fd158a1d42
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	VSTM4 MYLK PRG4 PCOLCE	2.12e-04	198	66	4	a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	VSTM4 MYLK PRG4 PCOLCE	2.12e-04	198	66	4	7b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCell	Caecum-T_cell-Th1\|T_cell / Region, Cell class and subclass	NEFM BAG3 CHORDC1 MED12	2.16e-04	199	66	4	13a80e6d3cf9c831edbe0644545071153e35f82b
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	MYLK KTN1 CRYBG1 EIF4G3	2.16e-04	199	66	4	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 CPXM2 PRG4 PCOLCE	2.16e-04	199	66	4	edd5300da1a3b758210ff8f949e9d1988b8bc7e2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	NEFM MAP2 PCLO NACA	2.16e-04	199	66	4	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	human_hepatoblastoma-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BAG3 CHORDC1 HSPA4 MRTFA	2.16e-04	199	66	4	e9c83555d2197b740797a9f33b64f8f7a7ba1ee2
ToppCell	3'-GW_trimst-1\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK ZFHX4 MYL6B NACA	2.16e-04	199	66	4	ecfb6381e2971a3e355e661a6df0021914485e74
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	NEFM MAP2 PCLO NACA	2.16e-04	199	66	4	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BIN1 BAG3 FYB1 RYR1	2.16e-04	199	66	4	e245851a5bddf56f7e13a7fb7c5fda2fd275dae3
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MAP2 MAP4 PCLO DLGAP4	2.20e-04	200	66	4	1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce
ToppCell	normal_Lung-Fibroblasts-COL14A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	BIN1 CPXM2 BAG3 PCOLCE	2.20e-04	200	66	4	6d8f6a6b3f61c529fbed1376659641030abf4f2c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYLK PTPRM MAP4 KTN1	2.20e-04	200	66	4	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm\|6m / Sample Type, Dataset, Time_group, and Cell type.	JPH1 BIN1 MYPN RYR1	2.20e-04	200	66	4	0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	NEFM ZFHX4 MAP2 PCLO	2.20e-04	200	66	4	68c90376e2779434e4ad8dc6dd3b44baa700e2f4
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK ZFHX4 SON PCOLCE	2.20e-04	200	66	4	ed941933457f8bf63b277025286ef0485e78f4d0
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	VSTM4 MYLK PRG4 PCOLCE	2.20e-04	200	66	4	c2c6f687c49ba790174b27c7b8b084af30b34c86
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	KIF23 ZAN C6orf132	2.55e-04	83	66	3	3aa95bf2d8ac37e648037faf3d54ebb243a4fde1
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	KIF23 ZAN C6orf132	2.55e-04	83	66	3	70804dd63221dd5ed26068ec1b50f11875abbc50
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	KIF23 ZAN C6orf132	2.55e-04	83	66	3	c1818411438f53aec76afead5c8caab701b95d39
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	KIF23 ZAN C6orf132	2.55e-04	83	66	3	1e7af8aaa20b4c2a77cf2f330113db0faa9d483c
Drug	Tiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A	KIF13B ZFHX4 MAP2 PTPRM MYO15A RYR1 MRTFA	1.39e-06	195	65	7	4402_UP
Drug	Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A	ZFHX4 PTPRM MAP4 PCLO FGF5 MYO15A MRTFA	1.54e-06	198	65	7	4139_DN
Drug	MAPS	NEFM KIF23 MAP2 MAP4 KTN1 TPX2	1.76e-05	191	65	6	CID000066161
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A	MYLK ZFHX4 MAP2 PCLO RYR1 MRTFA	2.04e-05	196	65	6	6845_UP
Drug	Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; HL60; HT_HG-U133A	BIN1 MAP4 CNGB3 PRRC2A HSPA4 MRTFA	2.16e-05	198	65	6	1268_UP
Drug	0225151-0000 [351320-15-5]; Up 200; 10uM; MCF7; HT_HG-U133A	CRYBG2 BIN1 DLGAP4 FGF5 MYO15A FYB1	2.16e-05	198	65	6	6384_UP
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	KIF23 MAP4 CNGB3 EIF4G3 PRRC2A MED12	2.22e-05	199	65	6	7203_DN
Drug	Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	KIF13B CRYBG2 MAP2 SLF2 PCLO CCNK	2.22e-05	199	65	6	3891_DN
Drug	Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A	BIN1 MYLK MAP4 DLGAP4 HSPA4 MRTFA	2.29e-05	200	65	6	1869_UP
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A	NEFM CRYBG2 MYLK ZFHX4 MAP4 CCNK	2.29e-05	200	65	6	2558_UP
Drug	PD 169316	NEFM MAP2 FGF5	7.70e-05	29	65	3	ctd:C408604
Drug	alpha-zearalanol	BIN1 TRIM25 ZAN	7.70e-05	29	65	3	CID000022283
Drug	2-isopropylpentanoic acid	NEFM MAP2	7.98e-05	5	65	2	CID000147513
Drug	2,3',5,5'-tetrachlorobiphenyl	TRIM25 MED12	7.98e-05	5	65	2	CID000038878
Drug	4-hydroxy-2,2',5,5'-tetrachlorobiphenyl	TRIM25 MED12	7.98e-05	5	65	2	CID000039971
Drug	NSC292228	BAG3 HSPA4 RYR1	8.53e-05	30	65	3	CID000001010
Drug	MBED	HSPA4 RYR1	1.19e-04	6	65	2	CID000129958
Drug	PP-9	CHORDC1 HSPA4	1.19e-04	6	65	2	CID000039977
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	NEFM CNGB3 BAG3 FYB1 HSPA4	1.82e-04	184	65	5	2686_UP
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TRIM25 MAP4 SPEN HSPA4 SON	1.87e-04	185	65	5	1673_DN
Drug	17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A	KIF13B BIN1 MAP4 BAG3 MRTFA	1.87e-04	185	65	5	6973_UP
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	KIF23 MAP4 TPX2 EIF4G3 PRRC2A	2.22e-04	192	65	5	7176_DN
Drug	6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	PRR12 MAP2 SPEN SON	2.25e-04	104	65	4	ctd:C000595015
Drug	Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A	BIN1 TRIM25 DLGAP4 MYO15A MED12	2.33e-04	194	65	5	5525_UP
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	KIF13B CNGB3 IFI35 CCNK MRTFA	2.33e-04	194	65	5	3166_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	BIN1 MYLK MAP4 FYB1 MRTFA	2.38e-04	195	65	5	4706_DN
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	CRYBG2 DLGAP4 FYB1 CCNK MRTFA	2.38e-04	195	65	5	3806_DN
Drug	radicicol; Up 200; 0.1uM; MCF7; HG-U133A	KIF23 KTN1 BAG3 SPEN HSPA4	2.38e-04	195	65	5	325_UP
Drug	S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; HL60; HT_HG-U133A	ZFHX4 MAP4 PCLO MYO15A CCNK	2.38e-04	195	65	5	3082_UP
Drug	Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A	MAP4 PCLO DLGAP4 CNGB3 MRTFA	2.38e-04	195	65	5	5270_DN
Drug	S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; HL60; HT_HG-U133A	CRYBG2 MAP4 DLGAP4 FGF5 FYB1	2.44e-04	196	65	5	3094_DN
Drug	ST021200; Down 200; 10uM; PC3; HT_HG-U133A	CRYBG2 BIN1 TRIM25 SLF2 PCOLCE	2.44e-04	196	65	5	7559_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; HL60; HG-U133A	KIF23 MAP4 SLF2 NACA BRD3	2.44e-04	196	65	5	1625_UP
Drug	Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	NEFM CRYBG2 BIN1 CCNK MRTFA	2.44e-04	196	65	5	6821_UP
Drug	Terconazole [67915-31-5]; Up 200; 7.6uM; HL60; HT_HG-U133A	TRIM25 MAP4 DLGAP4 MYO15A CCNK	2.44e-04	196	65	5	2484_UP
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A	KIF13B BIN1 ZFHX4 MAP4 MRTFA	2.50e-04	197	65	5	6964_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A	BIN1 MAP4 FGF5 FYB1 MRTFA	2.50e-04	197	65	5	6623_DN
Drug	Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	EFHC2 ATF7 CRYBG2 BIN1 PCLO	2.50e-04	197	65	5	6099_UP
Drug	5194442; Down 200; 20uM; PC3; HT_HG-U133A	TRIM25 NACA EIF4G3 HSPA4 MRTFA	2.50e-04	197	65	5	6594_DN
Drug	Picrotoxinin [17617-45-7]; Up 200; 13.6uM; HL60; HT_HG-U133A	CRYBG2 BIN1 ZFHX4 MAP4 PCLO	2.50e-04	197	65	5	2161_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	KIF23 MYLK MAP4 PCLO FGF5	2.50e-04	197	65	5	1224_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A	MYLK ZFHX4 MAP4 CCNK MRTFA	2.50e-04	197	65	5	2248_UP
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MAP4 DLGAP4 IFI35 HSPA4 RYR1	2.50e-04	197	65	5	1545_DN
Drug	Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A	BIN1 MYLK MAP4 CNGB3 FGF5	2.50e-04	197	65	5	2568_UP
Drug	Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A	MYLK MAP4 DLGAP4 IFI35 MRTFA	2.50e-04	197	65	5	1496_UP
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	CRYBG2 KIF23 TRIM25 CNGB3 RYR1	2.50e-04	197	65	5	2664_UP
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A	TRIM25 PTPRM MAP4 PCLO MRTFA	2.56e-04	198	65	5	5211_UP
Drug	Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A	ATF7 BIN1 MAP4 FYB1 MRTFA	2.56e-04	198	65	5	6033_UP
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	MAP4 HELZ IFI35 PRRC2A MRTFA	2.56e-04	198	65	5	2392_DN
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A	BIN1 MYLK DLGAP4 FGF5 MRTFA	2.56e-04	198	65	5	5406_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	PCLO DLGAP4 CNGB3 EIF4G3 MED12	2.56e-04	198	65	5	2047_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	KIF13B ZFHX4 MAP4 DLGAP4 MRTFA	2.56e-04	198	65	5	6043_DN
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A	CRYBG2 MAP4 PCLO DLGAP4 CCNK	2.56e-04	198	65	5	3642_DN
Drug	Megestrol acetate [595-33-5]; Down 200; 10.4uM; HL60; HT_HG-U133A	CRYBG2 DLGAP4 FGF5 FYB1 RYR1	2.56e-04	198	65	5	3091_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	CRYBG2 BIN1 MAP2 IFI35 MRTFA	2.56e-04	198	65	5	3883_DN
Drug	Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; HL60; HT_HG-U133A	NEFM PCLO CCNK MRTFA GABRA1	2.56e-04	198	65	5	3010_UP
Drug	W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A	ATF7 CRYBG2 KIF23 NACA SON	2.56e-04	198	65	5	440_DN
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; HL60; HT_HG-U133A	BIN1 PTPRM DLGAP4 CNGB3 FYB1	2.56e-04	198	65	5	2182_UP
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ATF7 MYLK DLGAP4 RYR1 MRTFA	2.62e-04	199	65	5	3546_UP
Drug	Propantheline bromide [50-34-0]; Up 200; 9uM; HL60; HT_HG-U133A	ZFHX4 PCLO CNGB1 RYR1 GABRA1	2.62e-04	199	65	5	3013_UP
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A	CRYBG2 BIN1 MAP2 MAP4 MRTFA	2.62e-04	199	65	5	2287_UP
Drug	Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A	MAP4 FGF5 FYB1 CCNK MRTFA	2.62e-04	199	65	5	5389_UP
Drug	TTNPB; Down 200; 0.1uM; MCF7; HG-U133A	ATF7 DLGAP4 CNGB3 FYB1 SON	2.62e-04	199	65	5	223_DN
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; HL60; HT_HG-U133A	KIF13B CRYBG2 BIN1 DLGAP4 MRTFA	2.62e-04	199	65	5	2367_UP
Drug	Bicuculline (+) [485-49-4]; Up 200; 10.8uM; HL60; HT_HG-U133A	ATF7 BIN1 MAP4 FYB1 CCNK	2.62e-04	199	65	5	2139_UP
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; HL60; HG-U133A	KTN1 NACA BRD3 MED12 SON	2.68e-04	200	65	5	2029_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A	MAP4 NACA BRD3 HSPA4 SON	2.68e-04	200	65	5	2027_DN
Drug	escina	MYLK MYL6B RYR1	2.71e-04	44	65	3	CID006433489
Drug	lactosyl lysosphingolipid	GLB1 RYR1	2.85e-04	9	65	2	CID006439268
Drug	cumate	GLB1 HSPA4	2.85e-04	9	65	2	CID000008721
Disease	Myopathy, Centronuclear, Autosomal Recessive	BIN1 RYR1	2.77e-05	4	64	2	C0410204
Disease	Antihypertensive use measurement	SRRM1 NACA BAG3 RBM6 FGF5	2.78e-04	265	64	5	EFO_0009927
Disease	creatine kinase measurement	BIN1 MYPN MRTFA	2.90e-04	59	64	3	EFO_0004534
Disease	Autosomal Dominant Myotubular Myopathy	BIN1 RYR1	3.56e-04	13	64	2	C3661489
Disease	Centronuclear myopathy	BIN1 RYR1	3.56e-04	13	64	2	C0175709
Disease	X-linked centronuclear myopathy	BIN1 RYR1	3.56e-04	13	64	2	C0410203
Disease	Congenital Structural Myopathy	BIN1 RYR1	3.56e-04	13	64	2	C0752282
Disease	Myopathy, Centronuclear, 1	BIN1 RYR1	3.56e-04	13	64	2	C4551952
Disease	Myopathy, Centronuclear, Autosomal Dominant	BIN1 RYR1	4.14e-04	14	64	2	C1834558
Disease	Tubular Aggregate Myopathy	BIN1 RYR1	4.14e-04	14	64	2	C0410207
Disease	Autosomal Recessive Centronuclear Myopathy	BIN1 RYR1	4.77e-04	15	64	2	C3645536
Disease	Congenital Fiber Type Disproportion	BIN1 RYR1	6.93e-04	18	64	2	C0546264
Disease	FEV/FEC ratio	PRR12 MAP2 PTPRM BAG3 MYO15A PRG4 HSPA4 PDHX MRTFA	1.28e-03	1228	64	9	EFO_0004713
Disease	chronic kidney disease	PTPRM MYPN FGF5 TET3	1.71e-03	235	64	4	EFO_0003884
Disease	basophil percentage of leukocytes	PRAM1 CHORDC1 EIF4G3 RYR1	1.94e-03	243	64	4	EFO_0007992
Disease	right ventricular ejection fraction measurement	BAG3 HSPA4	1.94e-03	30	64	2	EFO_0021816
Disease	putamen volume	KTN1 HELZ	2.07e-03	31	64	2	EFO_0006932

Protein segments in the cluster

Peptide	Gene	Start	Entry
KVPKKLEEIPPASPE	EP400	346	Q96L91
IVPVVPPTPPVVKKK	BRD3	226	Q15059
APGKIEKVKPPPSPT	AKAP2	766	Q9Y2D5
GREKTIKEPTKPEPP	FAM47DP	166	A6NHR8
IKEPTKPEPPKAPVS	FAM47DP	171	A6NHR8
KAAEPPPPKIPKIET	CCNK	346	O75909
PCSPPLKEKEVTPKP	ATF7	126	P17544
PEKRKEEKKPPPPVP	DLGAP4	916	Q9Y2H0
KKAPKREKSAPEPPP	CPXM2	86	Q8N436
EPKVKLPPKSQPPEK	PCOLCE	291	Q15113
KDSPDSPEPPNKKPL	INTS13	621	Q9NVM9
GTSKTPVPEKVPPPK	MYLK	961	Q15746
TTPPNKELPPSPEKK	MAP4	686	P27816
PIISKPKPKVEPPKE	HSPA4	781	P34932
TPAPPKDVTPPKDIT	MYO15A	1031	Q9UKN7
KDVTPPKDITPPKDV	MYO15A	1036	Q9UKN7
PKDITPPKDVLPEQK	MYO15A	1041	Q9UKN7
ENPEEKVPEKPPTPK	JPH1	436	Q9HDC5
KVPEKPPTPKESPHF	JPH1	441	Q9HDC5
KFEKVPEGPIPPSTP	GLB1	356	P16278
VSCKPPSPPPKIERK	EFHC2	376	Q5JST6
APPAPAKSIPVKKET	PCLO	986	Q9Y6V0
SPKDKVPFSVPKIPL	IFI35	36	P80217
VEIPKDVGPPPPVSK	PDHX	141	O00330
KPPVAVKPSSEEKPD	FYB1	61	O15117
KKVEPVPVTKQPTPP	KTN1	141	Q86UP2
PEKPDVEKEVKPPPK	MED12	701	Q93074
EPKEVKPETKPPEPK	GABRA1	396	P14867
IAPPKTVKPPEDQLK	HELZ	1831	P42694
VTVPEKKKPPSPIKP	FGF5	231	P12034
VEVKEPPGLPAKPPA	C6orf132	801	Q5T0Z8
PAKPVPGPEPFRKKE	GRID2IP	876	A4D2P6
LVLPPKKKDGPVDPP	CRYBG2	386	Q8N1P7
PPKLPLEKKPNPDKD	FOXR1	31	Q6PIV2
ESPPKRVPDPSPVTK	CRYBG1	131	Q9Y4K1
PPPSEKVEVKVPPAP	BAG3	356	O95817
VPPPPKHTPSKEVKQ	BIN1	341	O00499
KEEVPEPTPEPPKKQ	RYR1	4511	P21817
KPKPDPVLKSPSPVL	EIF4G3	221	O43432
TKGAATPKPVPEPEK	PTPRM	721	P28827
EVPFDPIKPKPPQSK	KIF23	236	Q02241
LKICDKPAKVPSPPP	KIF13B	1526	Q9NQT8
VKKEESPPPPKVVNP	RBM6	886	P78332
IEPGPVVPPKPSKKD	TAB3	616	Q8N5C8
VTDLPKKPPPPEVTD	PRAM1	76	Q96QH2
IQTPPPKKEPPKEET	PRRC2A	876	P48634
PKPLEQGDETPKPPK	PRRC2A	966	P48634
IAAEKLVPKPPPAKP	SETD5	596	Q9C0A6
TAVIPPKEKKPQATP	ST6GALNAC1	221	Q9NSC7
PKESKPKRVPPEKSP	SLF2	96	Q8IX21
PKPETPEKTTSEKPP	PRR12	1701	Q9ULL5
LPKARPTKVKAEPPP	PRR12	1781	Q9ULL5
EQEPPKVESKPKVPL	SPTY2D1	146	Q68D10
KEPPSLPGKEKPSPK	MRTFA	766	Q969V6
APTTPKKPAPTTPKE	PRG4	436	Q92954
KKPAPTTPKEPAPTT	PRG4	441	Q92954
APTTPKEPAPTTPKK	PRG4	561	Q92954
KEPAPTTPKKPAPTT	PRG4	566	Q92954
TTPKKPAPTTPKEPA	PRG4	571	Q92954
PTTPKEPAPTTTKKP	PRG4	586	Q92954
TTKKPAPTTPKEPAP	PRG4	596	Q92954
TLKEPAPTTPKKPAP	PRG4	716	Q92954
APTTPKKPAPKELAP	PRG4	721	Q92954
LKEPAPTTPKKPAPK	PRG4	786	Q92954
PTTPKKPAPKELAPT	PRG4	791	Q92954
SEKPPEPVKPEVKTT	CHORDC1	66	Q9UHD1
ESPKPSPAKKAPEPA	CNGB1	596	Q14028
SPAKKAPEPAPDTKP	CNGB1	601	Q14028
KPTAVPPVKESDDKP	CNGB3	166	Q9NQW8
LIPSPKPEPEKTSPK	ZFHX4	2346	Q86UP3
KTDPKEKIDIGLPPP	MRPL38	81	Q96DV4
APPPPVDSKKPLEEK	SPEN	2571	Q96T58
DVPVKKPAGPSISKP	MYL6B	6	P14649
KVPKPEPIPEPKEPS	SRRM1	246	Q8IYB3
EEKKSKKPPPVPALP	TRIM25	386	Q14258
PEALPTKPKVKVEAP	TET3	481	O43151
VVPGIDLPKEPPTPK	MAP2	246	P11137
KEKPDIPPAVPAKAP	VSTM4	246	Q8IW00
LKPAPPPTIEEKVAK	SON	2081	P18583
VPKEKPTIPTEKPTI	ZAN	586	Q9Y493
KPPVKPPTEPIGFDL	TPX2	421	Q9ULW0
PPPPTKKPEVVVEAP	KIAA1522	681	Q9P206
PSPKKTPAIPTPKEA	NACA	1556	E9PAV3
EPSSPVKEPPPVLAK	MYPN	641	Q86TC9
VKEPPPVLAKPKLDS	MYPN	646	Q86TC9
PVPKSPVEEKGKSPV	NEFM	616	P07197
PVEEKGKSPVPKSPV	NEFM	621	P07197
PKSPVEEKGKSPVPK	NEFM	631	P07197
SPVPKSPVEEKGKSP	NEFM	641	P07197
SPVEEKGKSPVPKSP	NEFM	646	P07197